Bringing a medical kit is essential to prepare yourself in case of emergency before traveling. But packing one isn't always ...

Thermo Fisher Scientific is breaking out the big bills to score a clinical research treat. With $8.875 billion in cash, the ...

Drop Access has been recognised as a finalist for the 2026 Zayed Sustainability Prize, one of the world’s leading awards for ...

KANSAS CITY, Mo. — On Tuesday, Research Medical Center is breaking ground on a new $35 million Brookside emergency room, set to open in 2027, at its location in the metro area. The new facility will ...

Researchers have revealed a surprising new side effect linked to GLP-1 agonists, such as Ozempic, Wegovy, Mounjaro and Zepbound. These popular treatments for diabetes and obesity could interfere with ...

The Urban Prepper explores Medical Module (Building a Bug Out Bag) highlighting storage, durability, and bug out preparedness. A GOP senator’s proposal to end the shutdown is the right move for the ...

Dr. Joseph Ricotta, a Delray Beach vascular surgeon, was recently named the No. 2 vascular surgeon in the U.S. by Newsweek. He moved to South Florida to address the underdiagnosed and undertreated ...

Healthtech startup The Medical Travel Company (TMTC) has raised $4.5 Mn (around INR 40 Cr) in a seed funding round led by Nexus Venture Partners The startup aims to deploy the fresh capital to expand ...

Theresa Gaffney is the lead Morning Rounds writer and reports on health care, new research, and public policy, with a particular interest in mental health, gender-affirming care, and LGBTQ+ patient ...

In the midst of a fight with Republicans over spending and a possible government shutdown, House Minority Leader Hakeem Jeffries, D-N.Y., criticized the Trump administration’s efforts to cut back ...

Adults with ADHD who recognize and regularly use their personal strengths report better well-being, improved quality of life and fewer mental health difficulties, according to a new international ...

Credit: Acrutis. Zoryve cream 0.05% is a once-daily, steroid-free cream for atopic dermatitis in patients aged 2 to 5 years. Zoryve cream 0.05% is expected to be available by the end of October 2025.